AI assistant
Sending…
MetaVia Inc. — Director's Dealing 2023
May 12, 2023
34919_dirs_2023-05-12_a8b03e10-869a-422c-a453-1286f1b3e9eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2023-05-11
Reporting Person: Glickman Mark A (Director)
More from MetaVia Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 10
Capital/Financing Update
2026
Apr 7
Regulatory Filings
2026
Apr 3